The Schedule of Pharmaceutical Benefits has been updated. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 May 2026
- Active Ingredient Prescribing - 1 May 2026
- Ex-manufacturer price - 1 May 2026
- Formulary Allocations - 1 May 2026
- Amendment to the schedule description of an item on the Pharmaceutical Benefits Schedule - 1 May 2026
- Medicine Status Website - 1 May 2026
- Public Consultation: Draft 2026-27 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP - 30 April 2026
- Have your say on the framework for consumer engagement in HTA - 29 April 2026
- Publication: 24-month Review of the Minimum Stockholding Requirements - 24 April 2026
- Updates and Resources for Remote Area Aboriginal Health Services (RAAHS) Prescriptions - 22 April 2026
- PBS and RPBS Section 85 and Section 100 Date of Supply Data - 20 April 2026
- Outcome Statement for February 2026 Stakeholder Sponsor Meeting: Multiple Myeloma - 17 April 2026
- PBS listing of lamotrigine for bipolar disorder - 8 April 2026
- PBAC Update March 2026 - 7 April 2026